These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25444800)

  • 1. Use of a current varicella vaccine as a live polyvalent vaccine vector.
    Murakami K; Mori Y
    Vaccine; 2016 Jan; 34(2):296-298. PubMed ID: 25444800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.
    Somboonthum P; Yoshii H; Okamoto S; Koike M; Gomi Y; Uchiyama Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Dec; 25(52):8741-55. PubMed ID: 18053621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
    Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
    Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity.
    Murakami K; Matsuura M; Ota M; Gomi Y; Yamanishi K; Mori Y
    Vaccine; 2015 Nov; 33(45):6085-92. PubMed ID: 26116253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
    Wu Q; Rivailler P; Xu S; Xu W
    J Virol; 2019 May; 93(9):. PubMed ID: 30728261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen.
    Shiraki K; Sato H; Yoshida Y; Yamamura JI; Tsurita M; Kurokawa M; Kageyama S
    J Med Virol; 2001 Jun; 64(2):89-95. PubMed ID: 11360239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
    Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
    Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
    Argaw T; Cohen JI; Klutch M; Lekstrom K; Yoshikawa T; Asano Y; Krause PR
    J Infect Dis; 2000 Mar; 181(3):1153-7. PubMed ID: 10720545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax.
    Kim JI; Jung GS; Kim YY; Ji GY; Kim HS; Wang WD; Park HS; Park SY; Kim GH; Kwon SN; Lee KM; Ahn JH; Yoon Y; Lee CH
    Virol J; 2011 Dec; 8():547. PubMed ID: 22176950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese scientists plan MMR alternative.
    Chou IH
    Nat Med; 2003 Nov; 9(11):1337. PubMed ID: 14595415
    [No Abstract]   [Full Text] [Related]  

  • 12. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild and attenuated vaccine RS-12 strains of mumps virus exhibit differences in amino acid sequences of their proteins.
    Alirezaie B; Shahbazi R; Safavieh SS; Mohammad A
    Acta Virol; 2014; 58(3):287-91. PubMed ID: 25283866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete DNA sequences of two oka strain varicella-zoster virus genomes.
    Tillieux SL; Halsey WS; Thomas ES; Voycik JJ; Sathe GM; Vassilev V
    J Virol; 2008 Nov; 82(22):11023-44. PubMed ID: 18787000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child.
    Kang HM; Kang KR; Kim YJ; Kang JH; Lee SY
    J Med Virol; 2023 Sep; 95(9):e29108. PubMed ID: 37715715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal varicella vaccine immunization in Japan.
    Yoshikawa T; Kawamura Y; Ohashi M
    Vaccine; 2016 Apr; 34(16):1965-70. PubMed ID: 26944711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.